A type of cardiovascular disease known to physicians as microvascular angina affects the heart’s tiniest arteries and causes chest pain. The disease is sneaky, in that it doesn’t show up on ...
VANCOUVER and MINNEAPOLIS, May 10, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire ‒ Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today announced that the first patient has been enrolled in ...
ROCHESTER, Minn. — A study at Mayo Clinic suggests that an hourglass-shaped stent could improve blood flow and ease severe and reoccurring chest pain in people with microvascular disease. Of 30 ...
Please provide your email address to receive an email when new articles are posted on . Compared with CT coronary angiography alone, coronary function testing improved endotype diagnosis for angina ...
In a randomized trial of patients with angina and no obstructive coronary artery disease (ANOCA), 6 weeks of treatment with diltiazem did not improve coronary vasomotor dysfunction — apart from ...
The Chinese expert consensus on the diagnosis and treatment of coronary microvascular diseases (2023 Edition) was written by the members of the Basic Research Group, Atherosclerosis and Coronary Heart ...
Please provide your email address to receive an email when new articles are posted on . In patients with heart attack without blocked arteries, a stratified treatment ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
WASHINGTON, DC—Patients with angina but no obstructive coronary artery disease (ANOCA) see no reduction in coronary vasomotor dysfunction when taking the calcium channel blocker diltiazem, data from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results